Baird Said a Genzyme (GENZ) Takeover Of BioMarin (BMRN) Makes Sense To Them
Get Alerts GENZ Hot Sheet
Price: $76.25 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Analysts at Robert W. Baird said a merger of Genzyme Corp. (Nasdaq: GENZ) and BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) makes sense to them.
In fact, the firm said, while the notion of a GENZ/BMRN combination isn't new, a combination could be substantially beneficial to GENZ – even when valuing BMRN shares as high as $30 per share.
The firm said a deal isn't part of their 'Buy' thesis for either name, but "after doing the math, we increasingly like this idea – for the benefit of both shareholder bases."
The firm said a deal would be highly accretive for GENZ beginning 2010. They said, "Even valuing BMRN shares as high as $30, GENZ could see accretion of $0.05, $0.23 and $0.40 for 2010-2012 respectively."
The firm has an Outperform rating and $76 price target on GENZ and an Outperform rating and $21 price target on BMRN.
In fact, the firm said, while the notion of a GENZ/BMRN combination isn't new, a combination could be substantially beneficial to GENZ – even when valuing BMRN shares as high as $30 per share.
The firm said a deal isn't part of their 'Buy' thesis for either name, but "after doing the math, we increasingly like this idea – for the benefit of both shareholder bases."
The firm said a deal would be highly accretive for GENZ beginning 2010. They said, "Even valuing BMRN shares as high as $30, GENZ could see accretion of $0.05, $0.23 and $0.40 for 2010-2012 respectively."
The firm has an Outperform rating and $76 price target on GENZ and an Outperform rating and $21 price target on BMRN.
You May Also Be Interested In
- Blackstone (BX) to Acquire Tropical Smoothie Cafe
- Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'
- Increasing unusual option volume: BKR NSC CYH FTAI SGMO BMRN LDOS
Create E-mail Alert Related Categories
Analyst Comments, Insiders' Blog, RumorsRelated Entities
UBS, Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!